Recent Articles
How Atypical PKCζ Regulates Path...
Roles of Serine/Threonine Phosph...
Histone Crotonylation: Reshaping...
TROP2 (TACSTD2): Target Biomarker and Matching Antibody Tools for Solid Tumor...
Structural Architecture and Oncogenic Signaling of TROP2 Transmembrane Glycoprotein TROP2, encoded by human TACSTD2 gene, is a 36–42 kDa type I transmembrane glycoprotein with layered modular structural domains that dictate...
TROP2 (TACSTD2): Target Biomarker and Matching Antibody Tools for Solid Tumor...
Structural Architecture and Oncogenic Signaling of TROP2 Transmembrane Glycoprotein TROP2, encoded by human TACSTD2 gene, is a 36–42 kDa type I transmembrane glycoprotein with layered modular structural domains that dictate...
Read More
Tumor-Associated Custom Antibodies: Versatile Research Reagents for Multi-Dim...
Core Unmet Demands for Custom Antibodies in Modern Oncology Basic Research Cancer progression arises from interconnected genomic mutations, epigenetic reprogramming, kinase pathway dysregulation and reshaped tumor immune microenvironments that demand...
Tumor-Associated Custom Antibodies: Versatile Research Reagents for Multi-Dim...
Core Unmet Demands for Custom Antibodies in Modern Oncology Basic Research Cancer progression arises from interconnected genomic mutations, epigenetic reprogramming, kinase pathway dysregulation and reshaped tumor immune microenvironments that demand...
Read More
Custom Antibody Development for Cancer Research: Specialized Reagents to Unra...
Unmet Reagent Demands Driving Custom Antibody Programs in Oncology Basic Research Tumor pathology arises from layered genomic mutations, dysregulated kinase signaling and reshaped immune microenvironment circuits that require highly specific...
Custom Antibody Development for Cancer Research: Specialized Reagents to Unra...
Unmet Reagent Demands Driving Custom Antibody Programs in Oncology Basic Research Tumor pathology arises from layered genomic mutations, dysregulated kinase signaling and reshaped immune microenvironment circuits that require highly specific...
Read More
FCM Multiplex Bead Assay: Revolutionary Technology for Simultaneous Multiplex...
Overview Accurate and high-throughput multiplex protein quantification is a core demand for researchers in life science and clinical testing. As a multiplex protein quantification technology built on flow cytometry, FCM...
FCM Multiplex Bead Assay: Revolutionary Technology for Simultaneous Multiplex...
Overview Accurate and high-throughput multiplex protein quantification is a core demand for researchers in life science and clinical testing. As a multiplex protein quantification technology built on flow cytometry, FCM...
Read More
Somatostatin Receptor 2 (SSTR2): An Independent Prognostic Biomarker for Neur...
Somatostatin receptor family comprises five GPCR subtypes with distinct tissue distribution; SSTR2 is prevalently overexpressed in gastroenteropancreatic and pulmonary neuroendocrine tumors, mediating multiple anti-proliferative signaling cascades and serving as an...
Somatostatin Receptor 2 (SSTR2): An Independent Prognostic Biomarker for Neur...
Somatostatin receptor family comprises five GPCR subtypes with distinct tissue distribution; SSTR2 is prevalently overexpressed in gastroenteropancreatic and pulmonary neuroendocrine tumors, mediating multiple anti-proliferative signaling cascades and serving as an...
Read More
Claudin 18.2 (CLDN18.2): A Lineage-Restricted Surface Target for Gastric Canc...
CLDN18.2 is a gastric lineage-restricted tight junction surface antigen, distinct from lung-specific CLDN18.1 and ectopically expressed in gastric, pancreatic and ovarian tumors. This article reviews Zolbetuximab anti-tumor mechanisms, preclinical monotherapy/chemocombination...
Claudin 18.2 (CLDN18.2): A Lineage-Restricted Surface Target for Gastric Canc...
CLDN18.2 is a gastric lineage-restricted tight junction surface antigen, distinct from lung-specific CLDN18.1 and ectopically expressed in gastric, pancreatic and ovarian tumors. This article reviews Zolbetuximab anti-tumor mechanisms, preclinical monotherapy/chemocombination...
Read More